And here is a fun and very bullish exercise - do the math on E88 not increasing, but merely maintaining current monthly revenue of $15 million, and factor in a modest 5% opex reduction.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025